ORM1 and cancer: ORM has also been studied as a single or combined urinary biomarker of inflammatory diseases and cancer, including lupus nephritis, adult-onset Still's disease, psoriasis, rheumatoid arthritis, sepsis, Crohn's disease, bladder cancer, and hepatocellular carcinoma (32–38).